Outcome of allogeneic haematopoetic stem cell transplantation for patients with primary or secondary resistance to imatinib in chronic myeloid leukaemia

被引：0
作者：
Koldehoff, M [1 ]
Elmaagacli, AH [1 ]
Steckel, NK [1 ]
Hlinka, M [1 ]
Ditschkowski, M [1 ]
Trenschel, R [1 ]
Peceny, R [1 ]
Beelen, DW [1 ]
机构：
[1] Univ Hosp, Essen, Germany
来源：
BONE MARROW TRANSPLANTATION | 2005年 / 35卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S236 / S236
页数：1
相关论文
共 50 条
  • [1] Imatinib preceding allogeneic stem cell transplantation in chronic myeloid leukaemia
    Perz, JB
    Sanz, J
    Ghorashian, S
    Chaidos, A
    Kaeda, J
    Szydlo, RM
    Marin, DC
    Olavarria, E
    Apperley, JF
    BONE MARROW TRANSPLANTATION, 2006, 37 : S227 - S227
  • [2] Outcome of allogeneic haematopoietic stem cell transplantation in patients with atypical chronic myeloid leukaemia
    Koldehoff, M.
    Elmaagacli, A. H.
    Ditschkowski, M.
    Beelen, D. W.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S428 - S428
  • [3] Allogeneic myeloablative haematopoietic stem cell transplantation for chronic myeloid leukaemia in the imatinib era
    Pavlu, J.
    Auner, H.
    Szydlo, R.
    Olavarria, E.
    Giles, C.
    Klammer, M.
    Kew, A.
    Milojkovic, D.
    Gabriel, I.
    Rezvani, K.
    Dazzi, F.
    Marin, D.
    Goldman, J.
    Apperley, J.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S49 - S49
  • [4] Imatinib mesylate treatment of patients with chronic myeloid leukaemia relapsing following allogeneic stem cell transplantation
    Conneally, E
    Carroll, P
    Neat, M
    Haslam, K
    Gately, K
    Ryan, J
    Lawler, M
    McCann, S
    BLOOD, 2004, 104 (11) : 248B - 249B
  • [5] Allogeneic haemotopoietic stem cell transplantation outcomes in imatinib-treated chronic myeloid leukaemia patients
    Ahn, H. K.
    Jung, C. W.
    Kim, K.
    Jang, J. H.
    Kim, D. H.
    Yoon, S. S.
    Kim, I. H.
    Sohn, S. K.
    Moon, J. H.
    Lee, J. H.
    Lee, K. H.
    Won, J. H.
    Lee, N. S.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S244 - S244
  • [6] Allogeneic and autologous haematopoetic stem cell transplantation for chronic lymphocytic leukaemia.
    Kulkarni, S
    Powles, R
    Cunningham, D
    Sirohi, B
    Treleaven, J
    Rudin, C
    Saso, R
    Singhal, S
    Mehta, J
    Matutes, E
    Catovsky, D
    BLOOD, 2001, 98 (11) : 393B - 393B
  • [7] Imatinib therapy for chronic myeloid leukaemia patients who relapse after allogeneic stem cell transplantation: a molecular analysis
    Martinelli, G
    Palandri, F
    Amabile, M
    Bonifazi, F
    Bandini, G
    Benedetti, F
    Usala, E
    Angelucci, E
    Tiribelli, M
    Fanin, R
    Sorio, M
    Arpinati, M
    Testoni, N
    Falcioni, S
    Giannini, M
    Poerio, A
    Soverini, S
    Pane, F
    Rosti, G
    Baccarani, M
    BONE MARROW TRANSPLANTATION, 2005, 35 : S236 - S236
  • [8] Outcome of allogeneic stem cell transplantation in patients with chronic myeloid leukaemia treated with second generation tyrosine kinases inhibitors after imatinib failure
    Palandri, F.
    Breccia, M.
    Iori, A. P.
    Bonifazi, F.
    Latagliata, R.
    Colaci, E.
    Torelli, G. F.
    Castagnetti, F.
    Valle, V.
    Usai, S.
    Martinelli, G.
    Dell'Agnola, C.
    Cingarlini, S.
    Rosti, G.
    Baccarani, M.
    Alimena, G.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S261 - S261
  • [9] Imatinib mesylate for treatment of relapse after allogeneic haematopoietic stem cell transplantation for chronic myeloid leukaemia
    Arqueros, V
    Espigares, A
    Roman, J
    Martin, A
    Jimenez, A
    Fernandez, C
    Capote, M
    Molina, J
    Heiniger, A
    Torres, A
    BONE MARROW TRANSPLANTATION, 2006, 37 : S228 - S228
  • [10] Allogeneic stem cell transplantation for advanced phase chronic myeloid leukaemia: experience from the imatinib era
    Holroyd, A.
    Pearce, R.
    Latif, A. L.
    Byrne, J.
    Roomallah, B.
    Clark, R. E.
    Marks, D. I.
    Shaw, B.
    Cook, G.
    Apperley, J. F.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S126 - S126
12345